Frequently Asked Questions

The Serranator® family is FDA-cleared for use in the peripheral vasculature.

You can read the full Instructions for Use (IFU) here.

A growing body of clinical data supports the use of SRT across a range of peripheral arterial lesions, including challenging below-the-knee (BTK) and above-the-knee (ATK) anatomy.

Published studies and registry data are available through our clinical evidence page.

If you’ve used an angioplasty balloon before, you’ll be able to use Serranator.

We offer a structured onboarding program for new users, including case proctoring, hands-on training opportunities, and access to our clinical team.

Connect with us to get started.

Our team partners directly with hospital administrators and value analysis committees (VACs) to support device evaluation and approval.

Contact us to get the process started.

Yes. Procedures using the Serranator® are generally billed under existing CPT codes for peripheral vascular intervention.

You can read more on Reimbursement here.